Anand Mehta to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Anand Mehta has written about Carcinoma, Hepatocellular.
Connection Strength
5.992
-
Beyond glyco-proteomics-Understanding the role of genetics in cancer biomarkers. Adv Cancer Res. 2023; 157:57-81.
Score: 0.681
-
N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes. Mol Cancer Res. 2021 11; 19(11):1868-1877.
Score: 0.629
-
Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review. World J Gastroenterol. 2019 Jun 21; 25(23):2947-2960.
Score: 0.542
-
N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging. J Proteome Res. 2018 10 05; 17(10):3454-3462.
Score: 0.513
-
Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma. PLoS One. 2018; 13(8):e0203149.
Score: 0.513
-
Biomarker analysis of fucosylated kininogen through depletion of lectin reactive heterophilic antibodies in hepatocellular carcinoma. J Immunol Methods. 2018 11; 462:59-64.
Score: 0.512
-
The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome. Curr Opin Pharmacol. 2018 08; 41:74-78.
Score: 0.502
-
Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC. Cancer Epidemiol Biomarkers Prev. 2017 05; 26(5):795-803.
Score: 0.461
-
Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2009 Jun; 18(6):1914-21.
Score: 0.269
-
Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J Proteome Res. 2009 Feb; 8(2):595-602.
Score: 0.264
-
Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res. 2006 Feb; 5(2):308-15.
Score: 0.214
-
Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A. 2005 Jan 18; 102(3):779-84.
Score: 0.199
-
Biomarkers for the Early Detection of Hepatocellular Carcinoma. Cancer Epidemiol Biomarkers Prev. 2020 12; 29(12):2495-2503.
Score: 0.143
-
Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry. Biomolecules. 2015 Oct 15; 5(4):2554-72.
Score: 0.105
-
MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays. PLoS One. 2014; 9(9):e106255.
Score: 0.097
-
Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73. Cancer Biomark. 2012; 11(4):161-71.
Score: 0.081
-
Overexpression of a1,6-fucosyltransferase in hepatoma enhances expression of Golgi phosphoprotein 2 in a fucosylation-independent manner. Int J Oncol. 2011 Jul; 39(1):203-8.
Score: 0.077
-
Hepatocellular carcinoma of the liver. Cancer Biomark. 2010; 9(1-6):375-83.
Score: 0.070
-
N-linked glycosylation of the liver cancer biomarker GP73. J Cell Biochem. 2008 May 01; 104(1):136-49.
Score: 0.063
-
Molecular viral oncology of hepatocellular carcinoma. Oncogene. 2003 Aug 11; 22(33):5093-107.
Score: 0.045
-
Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells. J Virol. 2003 May; 77(9):5503-6.
Score: 0.011